Helicobacter Pylori Infection

• CLINICAL_TRIALS trial_result · 2007-04-04
  Clinical Trial Update: Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection [Phase 3]

  Phase 3 trial evaluating a rescue therapy regimen of esomeprazole, moxifloxacin, and amoxicillin for Helicobacter pylori infection and chron…

• FDA approval · 2007-03-21
  FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for omeprazole by Sandoz Inc. This action updates the current approval for this generic drug.

• FDA approval · 2006-09-28
  FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Original Application (H2-Pharma, LLC)

  The FDA approved a new drug product consisting of bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride (H2-Pharma, LL…

• CLINICAL_TRIALS research · 2006-09-20
  Clinical Trial Update: Feasibility Study of Phototherapy System to Treat H Pylori [NA]

  Feasibility study of a phototherapy system to treat Helicobacter pylori is being evaluated in a clinical trial.

• CLINICAL_TRIALS research · 2006-09-11
  Clinical Trial Update: Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori [Phase 3]

  Phase 3 clinical trial evaluating a tailored treatment strategy for Helicobacter pylori infection based on CYP2C19 and 23S rRNA polymorphism…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.